Cargando…

Validity and reliability of a new incremental step test for people with chronic obstructive pulmonary disease

BACKGROUND: Incremental step tests (IST) can be used to assess exercise capacity in people with chronic obstructive pulmonary disease (COPD). The development of a new step test based on the characteristics of the incremental shuttle walk test (ISWT) is an important study to explore. We aimed to deve...

Descripción completa

Detalles Bibliográficos
Autores principales: Vilarinho, Rui, Serra, Lúcia, Águas, Ana, Alves, Carlos, Silva, Pedro Matos, Caneiras, Cátia, Montes, António Mesquita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987783/
https://www.ncbi.nlm.nih.gov/pubmed/35387847
http://dx.doi.org/10.1136/bmjresp-2021-001158
_version_ 1784682819181608960
author Vilarinho, Rui
Serra, Lúcia
Águas, Ana
Alves, Carlos
Silva, Pedro Matos
Caneiras, Cátia
Montes, António Mesquita
author_facet Vilarinho, Rui
Serra, Lúcia
Águas, Ana
Alves, Carlos
Silva, Pedro Matos
Caneiras, Cátia
Montes, António Mesquita
author_sort Vilarinho, Rui
collection PubMed
description BACKGROUND: Incremental step tests (IST) can be used to assess exercise capacity in people with chronic obstructive pulmonary disease (COPD). The development of a new step test based on the characteristics of the incremental shuttle walk test (ISWT) is an important study to explore. We aimed to develop a new IST based on the ISWT in people with COPD, and assess its validity (construct validity) and reliability, according to Consensus-based Standards for the selection of health status Measurement Instruments (COSMIN) recommendations. METHODS: A cross-sectional study was conducted in participants recruited from hospitals/clinics. During the recruitment, the participants who presented a 6-minute walk test (6MWT) report in the previous month were also identified and the respective data was collected. Subsequently, participants attended two sessions at their homes. IST was conducted on the first visit, along with the 1 min sit-to-stand (1MSTS) test. IST was repeated on a second visit, performed 5–7 days after the first one. Spearman’s correlations were used for construct validity, by comparing the IST with the 6MWT and the 1MSTS. Intraclass correlation coefficient (ICC(2,1)), SE of measurement (SEM) and minimal detectable change at 95% CI (MDC95) were used for reliability. The learning effect was explored with the Wilcoxon signed-rank test. RESULTS: 50 participants (70.8±7.5 years) were enrolled. IST was significant and moderate correlated with the 6MWT (ρ=0.50, p=0.020), and with the 1MSTS (ρ=0.46, p=0.001). IST presented an ICC(2,1)=0.96, SEM=10.1 (16.6%) and MDC95=27.9 (45.8%) for the number of steps. There was a statistically significant difference between the two attempts of the IST (p=0.030). CONCLUSION: Despite the significant and moderate correlations with the 6MWT and 1MSTS, the inability to full compliance with the COSMIN recommendations does not yet allow the IST to be considered valid in people with COPD. On the other hand, the IST is a reliable test based on its high ICC, but a learning effect and an ‘indeterminate’ measurement error were shown. TRIAL REGISTRATION NUMBER: NCT04715659.
format Online
Article
Text
id pubmed-8987783
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-89877832022-04-22 Validity and reliability of a new incremental step test for people with chronic obstructive pulmonary disease Vilarinho, Rui Serra, Lúcia Águas, Ana Alves, Carlos Silva, Pedro Matos Caneiras, Cátia Montes, António Mesquita BMJ Open Respir Res Chronic Obstructive Pulmonary Disease BACKGROUND: Incremental step tests (IST) can be used to assess exercise capacity in people with chronic obstructive pulmonary disease (COPD). The development of a new step test based on the characteristics of the incremental shuttle walk test (ISWT) is an important study to explore. We aimed to develop a new IST based on the ISWT in people with COPD, and assess its validity (construct validity) and reliability, according to Consensus-based Standards for the selection of health status Measurement Instruments (COSMIN) recommendations. METHODS: A cross-sectional study was conducted in participants recruited from hospitals/clinics. During the recruitment, the participants who presented a 6-minute walk test (6MWT) report in the previous month were also identified and the respective data was collected. Subsequently, participants attended two sessions at their homes. IST was conducted on the first visit, along with the 1 min sit-to-stand (1MSTS) test. IST was repeated on a second visit, performed 5–7 days after the first one. Spearman’s correlations were used for construct validity, by comparing the IST with the 6MWT and the 1MSTS. Intraclass correlation coefficient (ICC(2,1)), SE of measurement (SEM) and minimal detectable change at 95% CI (MDC95) were used for reliability. The learning effect was explored with the Wilcoxon signed-rank test. RESULTS: 50 participants (70.8±7.5 years) were enrolled. IST was significant and moderate correlated with the 6MWT (ρ=0.50, p=0.020), and with the 1MSTS (ρ=0.46, p=0.001). IST presented an ICC(2,1)=0.96, SEM=10.1 (16.6%) and MDC95=27.9 (45.8%) for the number of steps. There was a statistically significant difference between the two attempts of the IST (p=0.030). CONCLUSION: Despite the significant and moderate correlations with the 6MWT and 1MSTS, the inability to full compliance with the COSMIN recommendations does not yet allow the IST to be considered valid in people with COPD. On the other hand, the IST is a reliable test based on its high ICC, but a learning effect and an ‘indeterminate’ measurement error were shown. TRIAL REGISTRATION NUMBER: NCT04715659. BMJ Publishing Group 2022-04-05 /pmc/articles/PMC8987783/ /pubmed/35387847 http://dx.doi.org/10.1136/bmjresp-2021-001158 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Chronic Obstructive Pulmonary Disease
Vilarinho, Rui
Serra, Lúcia
Águas, Ana
Alves, Carlos
Silva, Pedro Matos
Caneiras, Cátia
Montes, António Mesquita
Validity and reliability of a new incremental step test for people with chronic obstructive pulmonary disease
title Validity and reliability of a new incremental step test for people with chronic obstructive pulmonary disease
title_full Validity and reliability of a new incremental step test for people with chronic obstructive pulmonary disease
title_fullStr Validity and reliability of a new incremental step test for people with chronic obstructive pulmonary disease
title_full_unstemmed Validity and reliability of a new incremental step test for people with chronic obstructive pulmonary disease
title_short Validity and reliability of a new incremental step test for people with chronic obstructive pulmonary disease
title_sort validity and reliability of a new incremental step test for people with chronic obstructive pulmonary disease
topic Chronic Obstructive Pulmonary Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987783/
https://www.ncbi.nlm.nih.gov/pubmed/35387847
http://dx.doi.org/10.1136/bmjresp-2021-001158
work_keys_str_mv AT vilarinhorui validityandreliabilityofanewincrementalsteptestforpeoplewithchronicobstructivepulmonarydisease
AT serralucia validityandreliabilityofanewincrementalsteptestforpeoplewithchronicobstructivepulmonarydisease
AT aguasana validityandreliabilityofanewincrementalsteptestforpeoplewithchronicobstructivepulmonarydisease
AT alvescarlos validityandreliabilityofanewincrementalsteptestforpeoplewithchronicobstructivepulmonarydisease
AT silvapedromatos validityandreliabilityofanewincrementalsteptestforpeoplewithchronicobstructivepulmonarydisease
AT caneirascatia validityandreliabilityofanewincrementalsteptestforpeoplewithchronicobstructivepulmonarydisease
AT montesantoniomesquita validityandreliabilityofanewincrementalsteptestforpeoplewithchronicobstructivepulmonarydisease